Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • SARS-CoV-2
  • Page 10

Tag: SARS-CoV-2

  • BiotechToday
  • World

Significance of Clinical correlations of SARS-CoV-2 antibody responses

bioxone October 28, 2020October 28, 2020 2

Sampriti Roy, University of Calcutta When an obvious cause of the disease is not present, a doctor takes into account the patient’s medical history, age, symptoms, test results and overall health to figure out what is wrong. By doing this and thus correlating different factors, they figure out what is most likely the issue.  This […]

Read More
  • BiotechToday
  • World

Can SARS-Cov-2 be neutralized potently, using engineered ACE2 receptor traps?

bioxone October 24, 2020October 24, 2020

Ayooshi Mitra, Amity University, Kolkata The crucial mechanism for severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) infections initializes with the binding of the viral spike protein to angiotensin-converting enzyme II (ACE2) human receptor protein. In order to create a set of ACE2 variants optimized for affinity and […]

Read More
  • BiotechToday
  • World

Is it possible to detect COVID 19 under 15 minutes?

bioxone October 23, 2020October 23, 2020

-Arpita Adhikary, Amity University Kolkata At the University of Technology Sydney, Australia, a rapid antigen test is developed using novel optical technology, iStrip technology is used to measure the saliva even in a very low amount and after 15 minutes result is displayed on the instrument’s small screen. This efficient, quick, and cost-effective ($A25 per […]

Read More
  • BiotechToday
  • World

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

bioxone October 22, 2020October 22, 2020

Devyani Goswami, Amity University Kolkata The spike proteins of the SARS-CoV-2 have been always the subject of interest in how it attaches to the human cells and causes the disease. Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor for SARS-CoV (the virus observed in 2003); they are present in the epithelia of the […]

Read More
  • BiotechToday
  • World

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

bioxone October 21, 2020October 21, 2020

Binayak Das, Team Bioxone A study conducted to unravel the potential of immunotherapy for patients affected by the covid-19 virus has announced that treatment with intravenous-immunoglobulin can potentially benefit covid-19 patients that are severely affected. Intravenous immunoglobulin or IVIG is the collection of IgG obtained from the blood serum of a large number of healthy […]

Read More
  • BiotechToday
  • World

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

bioxone October 20, 2020October 20, 2020

Sampriti Roy, Asutosh College, University of Calcutta SARS-CoV-2, the talk of the town (read “world”), still lacks information related to its origin and exact mechanism.  The virus, found to cause DAD (diffuse alveolar damage), leads to respiratory failure which appears to be the common mechanism of death in patients with severe COVID-19 infection. However, with […]

Read More
  • BiotechToday
  • World

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020 1

Anwesha Chatterjee, Amity University Kolkata The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection […]

Read More
  • BiotechToday
  • World

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of […]

Read More
  • BiotechToday
  • World

Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

bioxone October 18, 2020October 18, 2020

Sayak Banerjee, Amity University Kolkata Down syndrome (DS), also known as trisomy 21 is the most persistent aneuploidy characterized by a genetic disorder caused due to the triplication of the 21st human chromosome. This syndrome is particularly associated with the development of congenital heart disease, sleep apnoea, obesity, diabetes, premature ageing, and higher sensitivity to […]

Read More
  • BiotechToday
  • World

Is zinc deficiency leading to more COVID deaths?

bioxone October 17, 2020October 17, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Recently, researchers from various universities in Spain hypothesized that serum zinc level had a particular influence on COVID-19 patients, further stating it as a useful biomarker in predicting COVID-19 in its’ early stage. In an observational study of 249 COVID-19 patients to identify the severity of the disease and to […]

Read More

Posts navigation

1 … 6 7 8 9 10 11 12 13

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy